GE HealthCare to Acquire Sofie Biosciences for $945 Million
GE HealthCare announced it will acquire Sofie Biosciences for $945 million. This acquisition aims to strengthen GE HealthCare's radiopharmaceutical business, enhancing its capabilities in medical imaging and diagnostics. The deal reflects GE's strategic focus on expanding its presence in the radiopharma sector to better serve healthcare providers and patients.
Reuters·


